| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2009 | WO2009015366A2 Use of thyroid hormone conversion inhibitors to treat hyperproliferative disorders |
| 01/29/2009 | WO2009015363A1 Zearalenone macrolide derivatives and uses of the same |
| 01/29/2009 | WO2009015336A2 Controlled release interferon drug products and treatment of hcv infection using same |
| 01/29/2009 | WO2009015274A2 Polyethylene based bioactive agents |
| 01/29/2009 | WO2009015254A1 Triazine kinase inhibitors |
| 01/29/2009 | WO2009015248A1 Treatment of post-traumatic stress disorder |
| 01/29/2009 | WO2009015237A1 Novel compounds and methods of using them |
| 01/29/2009 | WO2009015236A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder |
| 01/29/2009 | WO2009015229A1 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
| 01/29/2009 | WO2009015214A2 Nanoparticles for imaging and treating chlamydial infection |
| 01/29/2009 | WO2009015208A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
| 01/29/2009 | WO2009015207A1 Small molecules for the protection of pancreatic cells |
| 01/29/2009 | WO2009015193A1 Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds |
| 01/29/2009 | WO2009015183A1 Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
| 01/29/2009 | WO2009015180A2 Novel compounds and methods of using them |
| 01/29/2009 | WO2009015169A1 Indole indane amide compounds useful as cb2 agonists and method |
| 01/29/2009 | WO2009015166A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 01/29/2009 | WO2009015133A1 Methods of activating irs-1 and akt |
| 01/29/2009 | WO2009015112A2 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 01/29/2009 | WO2009015107A1 Modulation of toll-like receptors for controlling neurogenesis |
| 01/29/2009 | WO2009015028A1 Substituted cyclohexenes |
| 01/29/2009 | WO2009015014A2 Multi-step method of pain and/or inflammation treatment |
| 01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
| 01/29/2009 | WO2009014972A1 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein |
| 01/29/2009 | WO2009014960A1 Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
| 01/29/2009 | WO2009014887A2 Stabilized immune modulatory rna (simra) compounds |
| 01/29/2009 | WO2009014770A2 Combinations of dopamine d2 receptor blockade with norepinephrine reuptake inhibition and with norepinephrine alpha 2 receptor blockade |
| 01/29/2009 | WO2009014759A2 Methods of inhibiting vzv replication and related compositions |
| 01/29/2009 | WO2009014745A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | WO2009014730A1 Macrocyclic serine protease inhibitors |
| 01/29/2009 | WO2009014676A1 Novel crystalline form of a dihydrochloride salt of a dipeptidyl peptidase-iv inhibitor |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014642A1 Combination of a de novo purine biosynthesis inhibitor and a cyclin dependent kinase inhibitor for the treatment of cancer |
| 01/29/2009 | WO2009014624A2 Nrf2 inducers for treating epidermolysis bullosa simplex |
| 01/29/2009 | WO2009014620A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 01/29/2009 | WO2009014534A1 Formulations of nonopioid and confined opioid analgesics |
| 01/29/2009 | WO2009014532A1 Stabilized tolterodine tartrate formulations |
| 01/29/2009 | WO2009014524A2 Anti-microbial photodynamic therapy |
| 01/29/2009 | WO2009014510A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/29/2009 | WO2009014491A1 The use of (3-amino-2-fluoropropyl) phosphinic acid for treatment of nerd |
| 01/29/2009 | WO2009014490A1 Combination of (3-amino-2-fluoropropyl)phosphinic acid and omeprazole for treating tlesr, gerd, and nerd |
| 01/29/2009 | WO2009014471A2 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 01/29/2009 | WO2009014417A2 An antiviral composition |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009014211A1 Alkylene oxide derivative and skin external preparation containing the same |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009014105A1 Novel carboxylic acid and antidepressant composition containing the same as active ingredient |
| 01/29/2009 | WO2009014101A1 Novel sulfonated sugar derivative, and use thereof for medicinal agent |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009014097A1 Novel histidine derivative |
| 01/29/2009 | WO2009014061A1 Emulsion compositions |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2009013901A1 Novel compound, method for production of the compound, pharmaceutical composition, anti-tumor agent, and use of the compound |
| 01/29/2009 | WO2009013885A1 Inhibitor of the differentiation of t cells into th1 cells |
| 01/29/2009 | WO2009013846A1 Pharmaceutical composition for amelioration of lower urinary tract symptom associated with prostatomegaly |
| 01/29/2009 | WO2009013724A2 Trimetal-arene clusters with anticancer activity |
| 01/29/2009 | WO2009013723A2 Ethyl pyruvate alone or in combination with mi cro- clustered water and use of the same |
| 01/29/2009 | WO2009013594A2 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 01/29/2009 | WO2009013569A1 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 01/29/2009 | WO2009013552A1 Controlled release pharmaceutical composition of tolperison hydrochloride |
| 01/29/2009 | WO2009013550A1 Composition and treatment |
| 01/29/2009 | WO2009013535A1 2-azabicyclo(2.2.2)octane derivatives as modulators of the glycine transporter i receptor |
| 01/29/2009 | WO2009013506A1 Cannabidiol for use in the treatment of transmissible neurodegenerative conditions |
| 01/29/2009 | WO2009013480A2 Antibacterial combination therapy |
| 01/29/2009 | WO2009013477A1 Compounds for treating duchenne muscular dystrophy |
| 01/29/2009 | WO2009013462A1 Thieno-pyridine derivatives as mek inhibitors |
| 01/29/2009 | WO2009013444A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 01/29/2009 | WO2009013435A2 Preservative-free prostaglandin-based ophthalmic solution |
| 01/29/2009 | WO2009013433A2 Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals |
| 01/29/2009 | WO2009013390A1 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 01/29/2009 | WO2009013360A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours |
| 01/29/2009 | WO2009013357A1 Use of yeast flakes for treating and/or preventing hyperinsulinemia |
| 01/29/2009 | WO2009013356A2 Anti-hiv tablet formulations comprising darunavir |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 01/29/2009 | WO2009013335A1 Organic compounds |
| 01/29/2009 | WO2009013334A1 Use of nor-bile acids in the treatment of arteriosclerosis |
| 01/29/2009 | WO2009013333A1 Alkylacetylene substituted acyltryptophanols |
| 01/29/2009 | WO2009013331A1 Topical antibiotic composition for the prevention of lyme disease |
| 01/29/2009 | WO2009013306A1 Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 01/29/2009 | WO2009013305A1 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | WO2009013293A1 Substituted cyclohexanecarboxamides useful as bace inhibitors |
| 01/29/2009 | WO2009013286A1 Organic compounds |
| 01/29/2009 | WO2009013244A1 Novel medicament in powder form comprising tiotropium and salmeterol, and lactose as excipient |
| 01/29/2009 | WO2009013237A2 Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof |
| 01/29/2009 | WO2009013211A2 New pyrazol derivatives |
| 01/29/2009 | WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | WO2009013168A1 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use as antioxidant |
| 01/29/2009 | WO2009013166A1 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient |
| 01/29/2009 | WO2009013162A1 Process for the preparation of heparanase-inhibiting sulfated hyaluronates and products obtained thereby |
| 01/29/2009 | WO2009013126A1 Substituted indazole derivatives active as kinase inhibitors |
| 01/29/2009 | WO2009013024A1 Medical device and use of a pharmaceutical composition |
| 01/29/2009 | WO2009013010A2 5ht6-ligands such as sulfonamide derivatives in drug- induced weight-gain |
| 01/29/2009 | WO2009012986A1 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 01/29/2009 | WO2009012960A2 Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production |
| 01/29/2009 | WO2009012910A1 Biologically-active stilbene derivatives and compositions thereof |
| 01/29/2009 | WO2009012908A2 Medicament for transdermal use on animals |
| 01/29/2009 | WO2009012791A1 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 01/29/2009 | WO2009012786A2 Nanoparticle-mediated treatment for inflammatory diseases |